Framingham, MA, United States of America

John Gregg Van Alsten

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 12.1

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: John Gregg Van Alsten: Innovator in Pharmaceutical Compositions

Introduction

John Gregg Van Alsten is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals and their applications. With a total of 3 patents to his name, Van Alsten continues to push the boundaries of innovation in his field.

Latest Patents

One of his latest patents focuses on co-crystals and pharmaceutical compositions comprising specific compounds. The invention relates to compositions and co-crystals that include a compound of formula I, where each of R and R is either H or another specified element. The co-crystal formers selected for this invention include adipic acid, citric acid, fumaric acid, maleic acid, succinic acid, or benzoic acid. Additionally, the patent outlines methods for making and using these compositions, showcasing Van Alsten's commitment to advancing pharmaceutical science.

Career Highlights

John Gregg Van Alsten is currently employed at Vertex Pharmaceuticals, Inc., a leading company in the biotechnology sector. His work at Vertex has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in drug development.

Collaborations

Some of his notable coworkers include Kwame Wiredu Nti-Addae and Michael Waldo. Their collective expertise enhances the innovative environment at Vertex Pharmaceuticals, fostering advancements in pharmaceutical technologies.

Conclusion

John Gregg Van Alsten is a distinguished inventor whose work in co-crystals and pharmaceutical compositions has made a significant impact in the industry. His contributions continue to shape the future of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…